{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:26:28Z","timestamp":1790803588562,"version":"4.1.0"},"reference-count":33,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: The clinical utility of reproductive carrier screening varies based on the genes tested, variant reporting policies, and the screened patient population. This study aims to evaluate the outcomes of carrier screening among reproductive couples undergoing testing in a routine clinical setting. Methods: A total of 1595 couples, primarily referred by reproductive endocrinology and infertility specialists, underwent couple-based carrier screening across 390 genes. Carrier states were assessed on a couple basis and reported only if a couple were at risk of having affected offspring. At-risk conditions were classified by severity, as well as their likelihood of clinical impact based on the specific variants detected in each at-risk couple. Secondary findings with potential personal utility were also evaluated. Results: Among the screened couples, 4.2% were at risk of having a child with a genetic condition. When limited to high-clinical-impact results, the at-risk couple rate decreased to 1.0%, with 44% of these cases involving CFTR, SMN1, or FMR1. Secondary findings were identified in 1.7% of individuals. Conclusions: Carrier screening for only CFTR, SMN1, and FMR1 will miss more than half of at-risk couples, underscoring the importance of broader carrier screening. Specific variants and their combinations can influence the predicted clinical impact of at-risk conditions, marking a key advantage of couple-based reporting. Secondary findings were common, highlighting the importance of discussing these potential findings during pre-test counselling.<\/jats:p>","DOI":"10.3390\/genes16060671","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:07:58Z","timestamp":1748592478000},"page":"671","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-1648","authenticated-orcid":false,"given":"Eric","family":"Lee","sequence":"first","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8916-3791","authenticated-orcid":false,"given":"Kaylee","family":"Orton","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kwan","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Faga","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trang","family":"Le","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranad","family":"Shaheen","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Nair","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cliffe","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Virtus Diagnostics, Suite 4, Level 1, 20-30 Blamey St, Revesby, NSW 2212, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41436-018-0321-0","article-title":"Clinical Utility of Expanded Carrier Screening: Results-Guided Actionability and Outcomes","volume":"21","author":"Beauchamp","year":"2019","journal-title":"Genet. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa2314768","article-title":"Nationwide, Couple-Based Genetic Carrier Screening","volume":"391","author":"Kirk","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","article-title":"Screening for Autosomal Recessive and X-Linked Conditions during Pregnancy and Preconception: A Practice Resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41525-022-00316-x","article-title":"Assessing Clinical Utility of Preconception Expanded Carrier Screening Regarding Residual Risk for Neurodevelopmental Disorders","volume":"7","author":"Boonsawat","year":"2022","journal-title":"NPJ Genom. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41436-019-0472-7","article-title":"Estimating Yields of Prenatal Carrier Screening and Implications for Design of Expanded Carrier Screening Panels","volume":"21","author":"Guo","year":"2019","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e63588","DOI":"10.1002\/ajmg.a.63588","article-title":"Estimation of Carrier Frequencies Utilizing the GnomAD Database for ACMG Recommended Carrier Screening and Finnish Disease Heritage Conditions in Non-Finnish European, Finnish, and Ashkenazi Jewish Populations","volume":"194","author":"Kandolin","year":"2024","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Capalbo, A., Valero, R.A., Jimenez-Almazan, J., Pardo, P.M., Fabiani, M., Jim\u00e9nez, D., Simon, C., and Rodriguez, J.M. (2019). Optimizing Clinical Exome Design and Parallel Gene-Testing for Recessive Genetic Conditions in Preconception Carrier Screening: Translational Research Genomic Data from 14,125 Exomes. PLoS Genet., 15.","DOI":"10.1371\/journal.pgen.1008409"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/humrep\/deab087","article-title":"Clinical Validity and Utility of Preconception Expanded Carrier Screening for the Management of Reproductive Genetic Risk in IVF and General Population","volume":"36","author":"Capalbo","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s10815-023-02876-y","article-title":"Carrier Burden of over 300 Diseases in Han Chinese Identified by Expanded Carrier Testing of 300 Couples Using Assisted Reproductive Technology","volume":"40","author":"Chen","year":"2023","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shi, M., Liauw, A.L., Tong, S., Zheng, Y., Leung, T.Y., Chong, S.C., Cao, Y., Lau, T.K., Choy, K.W., and Chung, J.P.W. (2021). Clinical Implementation of Expanded Carrier Screening in Pregnant Women at Early Gestational Weeks: A Chinese Cohort Study. Genes, 12.","DOI":"10.3390\/genes12040496"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/pd.6635","article-title":"Customizing Carrier Screening in the Chinese Population: Insights from a 334-gene Panel","volume":"44","author":"Liu","year":"2024","journal-title":"Prenat. Diagn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ajhg.2021.03.004","article-title":"The Landscape of Autosomal-Recessive Pathogenic Variants in European Populations Reveals Phenotype-Specific Effects","volume":"108","author":"Fridman","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tong, K., He, W., He, Y., Li, X., Hu, L., Hu, H., Lu, G., Lin, G., Dong, C., and Zhang, V.W. (2022). Clinical Utility of Medical Exome Sequencing: Expanded Carrier Screening for Patients Seeking Assisted Reproductive Technology in China. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.943058"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hotakainen, R., J\u00e4rvinen, T., Kettunen, K., Anttonen, A.-K., and Jakkula, E. (2024). Estimation of Carrier Frequencies of Autosomal and X-Linked Recessive Genetic Conditions Based on GnomAD v4.0 Data in Different Ancestries. Genet. Med., 101304.","DOI":"10.1016\/j.gim.2024.101304"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41431-019-0351-3","article-title":"Feasibility of Couple-Based Expanded Carrier Screening Offered by General Practitioners","volume":"27","author":"Schuurmans","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"(2017). Committee Opinion No. 690 Summary: Carrier Screening in the Age of Genomic Medicine. Obstet. Gynecol., 129, 595\u2013596.","DOI":"10.1097\/AOG.0000000000001947"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lazarin, G.A., Hawthorne, F., Collins, N.S., Platt, E.A., Evans, E.A., and Haque, I.S. (2014). Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114391"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/pd.6434","article-title":"An Overview of Reproductive Carrier Screening Panels for Autosomal Recessive and\/or X-linked Conditions: How Much Do We Know?","volume":"43","author":"Wang","year":"2023","journal-title":"Prenat. Diagn."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","article-title":"Carrier Screening for Recessive Disorders","volume":"20","author":"Antonarakis","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s10897-017-0160-1","article-title":"Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples","volume":"27","author":"Ghiossi","year":"2018","journal-title":"J. Genet. Couns."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41431-024-01742-4","article-title":"Perceptions of Severity and Their Influence on Reproductive Decision-Making Following Reproductive Genetic Carrier Screening","volume":"33","author":"Swainson","year":"2025","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/gim.2014.106","article-title":"Fragile X Full Mutation Expansions Are Inhibited by One or More AGG Interruptions in Premutation Carriers","volume":"17","author":"Nolin","year":"2015","journal-title":"Genet. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2009-0487","article-title":"Duplications of the Functional CYP21A2 Gene Are Primarily Restricted to Q318X Alleles: Evidence for a Founder Effect","volume":"94","author":"Kleinle","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/ajo.13206","article-title":"Socioeconomic Status and Uptake of Reproductive Carrier Screening in Australia","volume":"60","author":"Robson","year":"2020","journal-title":"Aust. N. Zealand J. Obstet. Gynaecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/gim.2017.134","article-title":"Reproductive Genetic Carrier Screening for Cystic Fibrosis, Fragile X Syndrome, and Spinal Muscular Atrophy in Australia: Outcomes of 12,000 Tests","volume":"20","author":"Archibald","year":"2018","journal-title":"Genet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ajmg.b.32065","article-title":"Prevalence of CGG Expansions of the FMR1 Gene in a US Population-based Sample","volume":"159B","author":"Seltzer","year":"2012","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/ajmg.a.38692","article-title":"FMR1 Premutation Frequency in a Large, Ethnically Diverse Population Referred for Carrier Testing","volume":"176","author":"Owens","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_29","unstructured":"eviQ (2024, October 16). ATM (Monoallelic Pathogenic Variants)\u2014Risk Management. Available online: https:\/\/www.eviq.org.au\/cancer-genetics\/adult\/risk-management\/1610-atm-monoallelic-pathogenic-variants-risk."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100317","DOI":"10.1016\/j.gim.2022.10.001","article-title":"Incidental Molecular Diagnoses and Heterozygous Risk Alleles in a Carrier Screening Cohort","volume":"25","author":"Reiner","year":"2023","journal-title":"Genet. Med."},{"key":"ref_31","first-page":"384","article-title":"Management Considerations for Clinically Relevant Findings on Expanded Carrier Screening in a Sperm Donor Applicant Population","volume":"4","author":"Isley","year":"2023","journal-title":"F S Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41591-020-0982-5","article-title":"Population Genetic Screening Efficiently Identifies Carriers of Autosomal Dominant Diseases","volume":"26","author":"Grzymski","year":"2020","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e250917","DOI":"10.1001\/jamanetworkopen.2025.0917","article-title":"Genomic Screening at a Single Health System","volume":"8","author":"Savatt","year":"2025","journal-title":"JAMA Netw. Open"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/6\/671\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:43:44Z","timestamp":1760031824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/6\/671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["genes16060671"],"URL":"https:\/\/doi.org\/10.3390\/genes16060671","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}